Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy Journal Article


Authors: Spisek, R.; Kukreja, A.; Chen, L. C.; Matthews, P.; Mazumder, A.; Vesole, D.; Jagannath, S.; Zebroski, H. A.; Simpson, A. J. G.; Ritter, G.; Durie, B.; Crowley, J.; Shaughnessy, J. D. Jr; Scanlan, M. J.; Gure, A. O.; Barlogie, B.; Dhodapkar, M. V.
Article Title: Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy
Abstract: Specific targets of cellular immunity in human premalignancy are largely unknown. Monoclonal gammopathy of undetermined significance (MGUS) represents a precursor lesion to myeloma (MM). We show that antigenic targets of spontaneous immunity in MGUS differ from MM. MGUS patients frequently mount a humoral and cellular immune response against SOX2, a gene critical for self-renewal in embryonal stem cells. Intranuclear expression of SOX2 marks the clonogenic CD138? compartment in MGUS. SOX2 expression is also detected in a proportion of CD138+ cells in MM patients. However, these patients lack anti-SOX2 immunity. Cellular immunity to SOX2 inhibits the clonogenic growth of MGUS cells in vitro. Detection of anti-SOX2 T cells predicts favorable clinical outcome in patients with asymptomatic plasmaproliferative disorders. Harnessing immunity to antigens expressed by tumor progenitor cells may be critical for prevention and therapy of human cancer. JEM © The Rockefeller University Press.
Keywords: controlled study; human tissue; protein expression; treatment outcome; human cell; neoplasms; cell proliferation; t-lymphocytes; biological markers; cells, cultured; multiple myeloma; cell growth; embryonic stem cell; transcription factors; cellular immunity; immune response; immunoglobulin g; disease progression; embryonic stem cells; health; adaptive immunity; monoclonal immunoglobulinemia; transcription factor sox2; myeloma; syndecan 1; paraproteinemias; hmgb proteins
Journal Title: Journal of Experimental Medicine
Volume: 204
Issue: 4
ISSN: 0022-1007
Publisher: Rockefeller University Press  
Date Published: 2007-04-16
Start Page: 831
End Page: 840
Language: English
DOI: 10.1084/jem.20062387
PUBMED: 17389240
PROVIDER: scopus
PMCID: PMC2118551
DOI/URL:
Notes: --- - "Cited By (since 1996): 47" - "Export Date: 17 November 2011" - "CODEN: JEMEA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lin-Chi Chen
    13 Chen